HealthTree Logo
search more_vert
person Sign In / Create Account
A New Drug for Relapsed/Refractory Myeloma Patients: Melflufen
A New Drug for Relapsed/Refractory Myeloma Patients: Melflufen image
Relapsed/Refractory Myeloma
event Apr 02, 2021 / 07:00PM - 08:00PM EDT

Event Description

A new treatment for multiple myeloma called melflufen (PEPAXTO®) was recently FDA-approved for relapsed or refractory multiple myeloma patients who have received at least four prior lines of therapy. Join us to hear Dr. Agne Paner of Rush University explain what the new therapy is, who qualifies for it, when it should be considered and how it works. Come with questions for the Q&A!

Schedule & Agenda

Jenny Ahlstrom
Jenny introduces the new Myeloma Community Chapter, the event agenda, and our featured speaker, Dr. Agne Paner. 
Dr. Agne Paner
Dr. Paner explains what the melflufen is, who qualifies for it, and how it works. Come with questions! 
Questions and Answers
Ask your questions about this new treatment to Dr. Paner! 

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Agne Paner, MD
Agne Paner, MD

Dr. Paner is an Associate Professor of Medicine in the Multiple Myeloma and Amyloidosis Program at Rush Medical College. Her research interests include clinical trials with innovative approaches to the treatment of patients with multiple myeloma and amyloidosis. She had hands-on experience in the HORIZON trial. She has been treating multiple myeloma for over 10 years and takes care of about 200 patients with multiple myeloma a year.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube